AR103086A1 - Composiciones y métodos para reducir las infecciones en aves de corral - Google Patents
Composiciones y métodos para reducir las infecciones en aves de corralInfo
- Publication number
- AR103086A1 AR103086A1 ARP150104160A ARP150104160A AR103086A1 AR 103086 A1 AR103086 A1 AR 103086A1 AR P150104160 A ARP150104160 A AR P150104160A AR P150104160 A ARP150104160 A AR P150104160A AR 103086 A1 AR103086 A1 AR 103086A1
- Authority
- AR
- Argentina
- Prior art keywords
- compositions
- methods
- composition
- reduce infections
- lactic acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
- A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/012—Coccidia antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Physiology (AREA)
- Food Science & Technology (AREA)
- Animal Husbandry (AREA)
- Birds (AREA)
- Tropical Medicine & Parasitology (AREA)
- Immunology (AREA)
- Nutrition Science (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Fodder In General (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Reivindicación 1: Una composición para reducir las infecciones por patógenos en un ave, caracterizada porque dicha composición comprende una cantidad eficaz de una bacteria productora de ácido láctico, donde dicha cantidad eficaz es una cantidad de dicha bacteria productora de ácido láctico que es capaz de reducir la coccidiosis en dicha ave. Reivindicación 7: La composición de cualquiera de las reivindicaciones 1 - 6, caracterizada porque dicha bacteria productora de ácido láctico es una cepa que se selecciona entre el grupo que consiste en las cepas LA51, LA45, NP28, y L411. Reivindicación 8: La composición de cualquiera de las reivindicaciones 1 - 7, caracterizada porque además comprende una vacuna contra la coccidiosis.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462093149P | 2014-12-17 | 2014-12-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR103086A1 true AR103086A1 (es) | 2017-04-12 |
Family
ID=56127599
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP150104160A AR103086A1 (es) | 2014-12-17 | 2015-12-17 | Composiciones y métodos para reducir las infecciones en aves de corral |
Country Status (3)
Country | Link |
---|---|
US (1) | US20160175369A1 (es) |
AR (1) | AR103086A1 (es) |
WO (1) | WO2016100674A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2689701C1 (ru) * | 2018-07-12 | 2019-05-28 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Кубанский государственный аграрный университет имени И.Т. Трубилина" | Способ выращивания перепелов |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3995541B2 (ja) * | 2002-06-28 | 2007-10-24 | 株式会社ゲン・コーポレーション | 抗鶏コクシジウム症組成物 |
AU2012334962B2 (en) * | 2011-11-11 | 2017-02-16 | Chr. Hansen A/S | Lactic acid bacteria and their use as dietary supplementals for poultry |
US9393275B2 (en) * | 2012-08-01 | 2016-07-19 | Novozymes A/S | Probiotic for amelioration of coccidiosis vaccine reaction |
-
2015
- 2015-12-17 US US14/973,034 patent/US20160175369A1/en not_active Abandoned
- 2015-12-17 AR ARP150104160A patent/AR103086A1/es unknown
- 2015-12-17 WO PCT/US2015/066393 patent/WO2016100674A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
US20160175369A1 (en) | 2016-06-23 |
WO2016100674A1 (en) | 2016-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR110684A1 (es) | Composiciones que comprenden cepas bacterianas y método de tratamiento | |
AR106768A1 (es) | Composiciones que comprenden cepas bacterianas | |
PH12016501577A1 (en) | Monobactam organic compounds for the treatment of bacterial infections | |
PE20180266A1 (es) | Composiciones que comprenden cepas bacterianas | |
CL2017003151A1 (es) | Formulaciones para vacunas contra la neoplasia y métodos para preparar las mismas | |
SV2017005462A (es) | Compuestos de isoxazol de ácido hidroxámico como inhibidores de lpxc | |
MX2016009898A (es) | Tratamientos para acne resistente. | |
ECSP20084373A (es) | Tiofencarboxamidas sustituidas y análogos de las mismas | |
CL2015001562A1 (es) | Método para obtener una vacuna de mycoplasma. | |
CL2015002755A1 (es) | Composiciones antibióticas de ceftolozano. | |
CR20160433A (es) | Nuevos compuestos | |
CL2011000877A1 (es) | Composicion inmunogena para el tratamiento y/o profilaxis de ganado contra infecciones microbiologicas porque comprende antigeno de mycoplasma bovis; metodo de coadministracion de dos o mas antigenos a un ganado bovino. | |
PH12016501988A1 (en) | Antibacterial compounds | |
BR112016012599A2 (pt) | composição, e, método para tratamento ou prevenção de uma infecção por staphylococcus aureus | |
PE20141452A1 (es) | Cepas de salmonella gallinarum modificadas avirulentas y composiciones farmaceuticas que las usan | |
PE20180036A1 (es) | Inhibidores de bromodominio | |
CL2017002451A1 (es) | Compuestos heterocíclicos novedosos y su uso en la prevención o tratamiento de las infecciones bacterianas | |
CL2017002803A1 (es) | Compuestos heterocíclicos y su uso en la prevención o tratamiento de las infecciones bacterianas | |
CL2017001329A1 (es) | Conjunto bacteriano sinergístico destinado a movilizar el fósforo del suelo. | |
CL2016000672A1 (es) | Bacteria aislada del género streptomyces | |
AR100365A1 (es) | Composición acuosa que comprende ibuprofeno y paracetamol en combinación, proceso para fabricarla y dispositivo inyector para administrarla | |
BR112015016033A8 (pt) | composições farmacêuticas para tratamento de infecções por bactérias, e seus usos | |
CL2017001818A1 (es) | Bacteria de ácido láctico y su uso para el tratamiento de mastitis | |
CO2017010271A2 (es) | Archaebacteria en alimento para animales bioactivo, método para hacer la composición y métodos que emplean la composición | |
CL2020000859A1 (es) | Derivados de ácido glucónico para ser usados en el tratamiento y/o prevención de infecciones microbianas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |